Lisa Bonadonna

Title: Lisa Bonadonna: Innovator in Immunology

Introduction

Lisa Bonadonna is a prominent inventor based in Elsternwick, Australia. She has made significant contributions to the field of immunology, particularly through her innovative patents. With a total of 2 patents, her work focuses on the development of proteins and methods that enhance our understanding of immunoglobulin interactions.

Latest Patents

One of her latest patents is centered around an Fc receptor for immunoglobulin. This invention provides nucleotide sequences encoding a protein with Fc receptor activity, which is capable of binding the Fc region of immunoglobulin. Additionally, it includes polypeptides with Fc receptor activity, proteins that exhibit enhanced or reduced immunoglobulin binding ability, and methods for determining the presence of immunoglobulin. These advancements have implications for detecting immune complexes, removing immunoglobulin from body fluids, and treating diseases using the proteins developed.

Another notable patent involves DNA encoding for an Fc receptor for immunoglobulin. This receptor, derived from mouse or human cells, binds to the Fc portion of immunoglobulin and comprises transmembrane proteins with specific amino acid characteristics. The invention also includes a nucleotide sequence, gene, cDNA clone, or vector capable of encoding this receptor, further advancing the field of immunology.

Career Highlights

Throughout her career, Lisa Bonadonna has worked with esteemed organizations such as the Austin Research Institute and the University of Melbourne. Her contributions to these institutions have been instrumental in advancing research in immunology and related fields.

Collaborations

Lisa has collaborated with notable colleagues, including Ian F McKenzie and Bernadette M Scott. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Lisa Bonadonna's work in immunology exemplifies the impact of innovative thinking in scientific research. Her patents not only contribute to the understanding of immunoglobulin interactions but also pave the way for potential therapeutic applications. Her career reflects a commitment to advancing knowledge in her field, making her a significant figure in the world of inventions.